Breaking the disulfide bridge by extracellular reduced thioredoxin (rTRX) activated TRPC5 homotetramer and TRPC5/1 heterotetramer in secretory fibroblast-like synoviocytes and suppressed synovial fluid secretion, leading to rheumatoid arthritis. Here, TRPC5 is linked to rheumatoid arthritis.